|
Records 1-30 (of 33 Records) |
| Query Trace: recent[original query] |
|---|
| Wastewater Surveillance: A New Frontier for Public Health CDC, June 30, 2022 
Tracking the spread of SARS-CoV-2, the virus that causes COVID-19 continues to be vital to interrupting chains of transmission, preventing new cases of illness, and saving lives. Scientists can test community wastewater samples to detect the ribonucleic acid, or “RNA,” of SARS-CoV-2. Wastewater testing is a novel approach for monitoring the virus, providing timely information about the changing prevalence of COVID-19 in different communities.
|
| Delta reinfection risk low among unvaccinated children. Ledford Heidi et al. Nature 2022 6
Children and adolescents who had not been vaccinated against COVID-19 mounted a long-lasting immune response to infection with the Delta variant of the coronavirus SARS-CoV-2, according to a large study of Israeli health records. But scientists warn that the findings do not mean that children should not be vaccinated against COVID-19.
|
| Booster dose of BNT162b2 after two doses of CoronaVac improves neutralization of SARS-CoV-2 Omicron variant GRF Campos et al, Comm Medicine, June 29, 2022
Based on viral microneutralization assays, we evaluated in 90 individuals the impact on antibody neutralization induction, against Omicron variant, by a booster dose of BNT162b2 mRNA vaccine after the CoronaVac primary vaccination scheme. Here we show that the percentage of seroconverted individuals 30 and 60 days after CoronaVac scheme was 16.6% and 10%, respectively. After booster dose administration, the seroconvertion rate increased to 76.6%. The neutralization mean titer against Omicron in the CoronaVac protocol decreased over time, but after the booster dose, the mean titer increased 43.1 times.
|
| RT-LAMP-CRISPR-Cas13a technology as a promising diagnostic tool for the SARS-CoV-2 virus CO Cartagena et al, MEDRXIV, June 30, 2022
|
| Severity of Omicron (B.1.1.529) and Delta (B.1.1.617.2) SARS-CoV-2 infection among hospitalised adults: a prospective cohort study C Hyams et al, MEDRXIV, June30, 2022
|
| A Semi-Supervised Learning Approach for COVID-19 Detection from Chest CT Scans. Zhang Yong, et al. Neurocomputing 2022 0 0.
|
| Deep transfer learning for the recognition of types of face masks as a core measure to prevent the transmission of COVID-19. Mar-Cupido Ricardo, et al. Applied soft computing 2022 0 0. 109207
|
| COVID-19 severity detection using machine learning techniques from CT-images. Aswathy A L, et al. Evolutionary intelligence 2022 0 0. 1-9
|
| A novel model to predict severe COVID-19 and mortality using an artificial intelligence algorithm to interpret chest radiographs and clinical variables. Munera Nicolás, et al. ERJ open research 2022 0 0. (2)
|
| Analysis of mHealth research: mapping the relationship between mobile apps technology and healthcare during COVID-19 outbreak. El-Sherif Dina M, et al. Globalization and health 2022 0 0. (1) 67
|
| Novel extreme regression-voting classifier to predict death risk in vaccinated people using VAERS data. Saad Eysha, et al. PloS one 2022 0 0. (6) e0270327
|
| Immune Response after 2 Doses of BNT162b2 mRNA COVID-19 Vaccinations in Children and Adolescents with Cancer and Hematologic Diseases. Poparn Hansamon, et al. Asian Pacific journal of cancer prevention : APJCP 2022 0 0. (6) 2049-2055
|
| Absence of neutralizing antibodies against the Omicron SARS-CoV-2 variant in convalescent sera from individuals infected with the ancestral SARS-CoV-2 virus or its Gamma variant. Villas-Boas Lucy Santos, et al. Clinics (Sao Paulo, Brazil) 2022 0 0. 100068
|
| Epidemiological characteristics and transmission dynamics of the outbreak caused by the SARS-CoV-2 Omicron variant in Shanghai, China: a descriptive study. Chen Zhiyuan, et al. medRxiv : the preprint server for health sciences 2022 0 0.
|
| Temporal trends in COVID-19 outcomes among patients with systemic autoimmune rheumatic diseases: From the first wave to Omicron. Kawano Yumeko, et al. medRxiv : the preprint server for health sciences 2022 0 0.
|
| Molecular detection of omicron SARS-CoV-2 variant is achieved by RT-LAMP despite genomic mutations. Almeida Letícia Trindade, et al. Memorias do Instituto Oswaldo Cruz 2022 0 0. e220050
|
| Natural selection plays a significant role in governing the codon usage bias in the novel SARS-CoV-2 variants of concern (VOC). Tyagi Neetu, et al. PeerJ 2022 0 0. e13562
|
| Severe Acute Respiratory Syndrome Coronavirus 2 Variants-Possibility of Universal Vaccine Design: A Review. Yoon Eunhye, et al. Computational and structural biotechnology journal 2022 0 0.
|
| Explosive outbreak of SARS-CoV-2 Omicron variant is associated with vertical transmission in high-rise residential buildings in Hong Kong. Cheng Vincent Chi-Chung, et al. Building and environment 2022 0 0. 109323
|
| Molecular characteristics, immune evasion, and impact of SARS-CoV-2 variants. Sun Cong, et al. Signal transduction and targeted therapy 2022 0 0. (1) 202
|
| COVID-19 due to the B.1.617.2 (Delta) variant compared to B.1.1.7 (Alpha) variant of SARS-CoV-2: a prospective observational cohort study. Kläser Kerstin, et al. Scientific reports 2022 0 0. (1) 10904
|
| COVID-19 in Fabry disease: a reference center prospective study. Bothou Christina, et al. Orphanet journal of rare diseases 2022 0 0. (1) 250
|
| Immunogenicity and reactogenicity of SARS-CoV-2 vaccines BNT162b2 and CoronaVac in healthy adolescents. Rosa Duque Jaime S, et al. Nature communications 2022 0 0. (1) 3700
|
| Temporal Changes in the Accessory Protein Mutations of SARS-CoV-2 Variants and Their Predicted Structural and Functional Effects. Cruz Christian Alfredo, et al. Journal of medical virology 2022 0 0.
|
| The SARS-CoV-2 Delta variant induces an antibody response largely focused on class 1 and 2 antibody epitopes. Greaney Allison J, et al. PLoS pathogens 2022 0 0. (6) e1010592
|
| Outcome and effect of vaccination in SARS-CoV-2 Omicron infection in hemodialysis patients: a cohort study. Ashby Damien R, et al. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2022 0 0.
|
| Spike Protein Cleavage-Activation in the Context of the SARS-CoV-2 P681R Mutation: an Analysis from Its First Appearance in Lineage A.23.1 Identified in Uganda. Lubinski Bailey, et al. Microbiology spectrum 2022 0 0. e0151422
|
| The Zinc Proteome of SARS-CoV-2. Andreini Claudia, et al. Metallomics : integrated biometal science 2022 0 0.
|
| A Method for Variant Agnostic Detection of SARS-CoV-2, Rapid Monitoring of Circulating Variants, and Early Detection of Emergent Variants Such as Omicron. Lai Eric, et al. Journal of clinical microbiology 2022 0 0. e0034222
|
| Prevalence of acute olfactory dysfunction differs between variants of SARS-CoV-2-results from chemosensitive testing in wild type, VOC alpha (B.1.1.7) and VOC delta (B.1617.2). Hintschich Constantin A, et al. European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery 2022 0 0.
|
Disclaimer: Articles listed in the Public Health
Knowledge Base are selected by the CDC Office of Public Health
Genomics to provide current awareness of the literature and news.
Inclusion in the update does not necessarily represent the views of
the Centers for Disease Control and Prevention nor does it imply
endorsement of the article's methods or findings. CDC and DHHS assume
no responsibility for the factual accuracy of the items presented. The
selection, omission, or content of items does not imply any
endorsement or other position taken by CDC or DHHS. Opinion, findings
and conclusions expressed by the original authors of items included in
the update, or persons quoted therein, are strictly their own and are
in no way meant to represent the opinion or views of CDC or DHHS.
References to publications, news sources, and non-CDC Websites are
provided solely for informational purposes and do not imply
endorsement by CDC or DHHS.
- Page last reviewed:Oct 1, 2021
- Page last updated:Jul 01, 2022
- Content source: